Skip to main content

CPS TECHNOLOGIES CORP/DE/

For the period ended Mar 28, 2026. Filed May 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 28, 2026 · Filed May 5, 2026

CPSH$3.83+6.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

Item 1. FINANCIAL STATEMENTS (Unaudited)

Condensed Balance Sheets (Unaudited)

March 28, 2026December 27, 2025
ASSETS
Current assets:
Cash and cash equivalents$5,724,339$4,466,198
Marketable securities, at fair value6,797,9528,769,363
Accounts receivable-trade3,779,0895,235,307
Accounts receivable-other201,013380,948
Inventories, net7,143,7275,598,407
Prepaid expenses and other current assets331,411299,829
Total current assets23,977,53124,750,052
Property and equipment:
Production equipment10,528,77310,647,170
Furniture and office equipment910,310910,310
Leasehold improvements997,830997,830
Total cost12,436,91312,555,310
Accumulated depreciation and amortization(10,801,044)(10,877,927)
Construction in progress828,107459,671
Net property and equipment2,463,9762,137,054
Net intangible assets20,79421,778
Right-of-use lease asset300,000336,000
Deferred taxes, net2,349,5602,266,854
Total Assets$29,111,86129,511,738
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable3,337,5893,363,233
Accrued expenses577,219907,910
Deferred revenue450,579238,044
Lease liability, current portion163,000162,000
Total current liabilities4,528,3874,671,187
Deferred revenue – long term31,27731,277
Long term lease liability137,000174,000
Total liabilities4,696,6644,876,464
Commitments & Contingencies
Stockholders’ equity:
Common stock, $0.01 par value, authorized 20,000,000 shares; issued 18,151,767 and 18,132,767 shares; outstanding 18,006,963 and 17,988,634 shares at each March 28, 2026 and December 27, 2025181,510181,320
Preferred stock, no shares issued or outstanding––
Additional paid-in capital50,377,08150,295,019
Accumulated other comprehensive income (loss)(4,618)139
Accumulated deficit(25,764,070)(25,469,891)
Less cost of 144,804 and 144,133 common shares repurchased at each March 28, 2026 and December 27, 2025(374,706)(371,313)
Total stockholders’ equity24,415,19724,635,274
Total liabilities and stockholders’ equity$29,111,861$29,511,738

Condensed Statements of Operations and Other Comprehensive Income (Loss)

(Unaudited)

Fiscal Quarters Ended
March 28, 2026March 29, 2025
Product sales$7,028,748$7,505,921
Cost of product sales6,421,8706,274,920
Gross profit606,8781,231,001
Selling, general, and administrative expenses1,129,5121,101,350
Operating income (loss)(522,634)129,651
Other income, net146,20550,476
Income (loss) before income taxes(376,429)180,127
Income tax provision (benefit)(82,250)84,165
Net income (loss)$(294,179)$95,962
Other comprehensive income
Net unrealized gains (losses) on available for sale securities(4,757)2,037
Reclassification adjustment for gains included in net income-(16,237)
Total other comprehensive income(4,757)(14,200)
Comprehensive income (loss)(298,936)81,762
Net income (loss) per basic common share$(0.02)$0.01
Weighted average number of basic common shares outstanding17,997,08814,525,960
Net income (loss) per diluted common share$(0.02)$0.01
Weighted average number of diluted common shares outstanding17,997,08814,543,911

CPS TECHNOLOGIES CORP.

CONDENSED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

FOR THE THREE MONTHS ENDED MARCH 28, 2026 AND MARCH 29, 2025

Common Stock
Number of shares issuedPar ValueAdditional paid-in capitalAccumulated deficitAccumulated other comprehensive income (loss)Stock repurchasedTotal stockholders’ equity
Balance at December 27, 202518,132,767$181,320$50,295,019$(25,469,891)$139$(371,313)$24,635,274
Share-based compensation expense——48,249———48,249
Net unrealized gains on available for sale securities————(4,757)—(4,757)
Employee option exercises19,00019033,813(3,393)30,610
Net loss———(294,179)——(294,179)
Balance at March 28, 202618,151,767$181,510$50,377,081$(25,764,070)$(4,618)$(374,706)$24,415,197
Balance at December 28, 202414,661,487$146,615$40,580,387$(25,890,245)15,500$(340,138)$14,512,119
Share-based compensation expense——122,186———122,186
Net unrealized gains on available for sale securities————2,037—2,037
Reclassification adjustment for gains included in net income————(16,237)—(16,237)
Net income———95,962——95,962
Balance at March 29,202514,661,487146,615$40,702,573$(25,794,283)1,300$(340,138)$14,716,067

Condensed Statements of Cash Flows (Unaudited)

Fiscal Quarters Ended
March 28, 2026 · March 29, 2025
Cash flows from operating activities:
Net income (loss)$(294,179)$95,962
Adjustments to reconcile net income (loss) to cash (used in) operating activities:
Depreciation and amortization151,198164,738
Share-based compensation48,249122,186
Deferred taxes(82,706)83,709
Realized gain on sale of marketable securities(29,970)(26,068)
Changes in:
Accounts receivable - trade1,456,218(1,444,442)
Accounts receivable - other179,935(33,407)
Inventories(1,545,320)(481,767)
Prepaid expenses and other current assets(31,582)91,222
Accounts payable(25,644)81,840
Accrued expenses(330,691)157,653
Deferred revenue212,535(64,349)
Net cash (used in) operating activities(291,957)(1,252,723)
Cash flows from investing activities:
Purchases of property and equipment(475,836)(93,070)
Acquisition cost of patents and trademarks(1,300)-
Proceeds from sale of marketable securities5,257,000518,000
Purchases of marketable securities(3,260,376)(514,845)
Net cash provided by (used in) investing activities1,519,488(89,915)
Cash flows from financing activities:
Proceeds from employee stock options30,610-
Payments on note payable-(8,130)
Net cash provided by (used in) financing activities30,610(8,130)
Net increase (decrease) in cash and cash equivalents1,258,141(1,350,768)
Cash and cash equivalents at beginning of period4,466,1983,280,687
Cash and cash equivalents at end of period$5,724,339$1,929,919
Supplemental disclosures of cash flows information:
Cash paid for interest$-$26
Net exercise of stock options$3,393$-

Notes to Condensed Financial Statements

(Unaudited)

(1) Nature of Business

CPS Technologies Corporation (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive and other industries. The Company’s primary advanced material solution is metal-matrix composites ("MMC") which are a combination of metal and ceramic.

CPS also assembles housings and packages for hybrid circuits. These housings and packagesmayinclude components made of metal-matrix composites or theymayinclude components made of more traditional materials such as aluminum, copper-tungsten, etc.

Using its proprietary MMC technology, the Company also produces light-weight armor, particularly for extreme environments and heavy threat levels.

The Company also engages in research and development, in some cases government funded and in others internally funded, focused on developing new products in response to customer requirements. These products expand our offerings in existing markets and enable penetration into new markets.

The Company sells into several end markets including the wireless communications infrastructure market, high-performance microprocessor market, motor controller market, and other microelectronic and defense markets.

(2) Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form10-Q, these notes are condensed and donot contain all disclosures required by generally accepted accounting principles and should be read in conjunction with the audited financial statements and related notes included in the 2025 Annual Report.

The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.

The Company’s balance sheet atDecember 27, 2025has been derived from the audited financial statements at that date, but doesnot include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form10-K for the year endedDecember 27, 2025and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.cpstechnologysolutions.com.

The results of operations for interim periods arenot necessarily indicative of the results to be expected for the full year.

(3)* Future Application of Accounting Standards*

Disaggregation of Income Statement Expenses

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40) ("ASU 2024-03"). The standard requires certain details for expenses presented on the face of the Statements of Operations and Comprehensive Income (Loss) as well as selling expenses to be presented in the notes to the financial statements on an interim and annual basis. The provisions of the standard are effective for public companies for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 31, 2027. The amendment can be applied either prospectively or retrospectively, with early adoption permitted. The Company is currently assessing the impact of this standard.

(4) Use of Estimates

The preparation of the Condensed Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

(5) Marketable Securities

Investments consist of U.S. Treasury Bills with maturities up to one year. Since it is not currently managements intention to hold these debt securities until the maturity dates, these have been classified as available-for-sale (“AFS”) and are recorded on the balance sheet at fair value, with changes in fair value recorded as a component of other comprehensive income.

(6) Fair value of Marketable Securities

ASC 820, Fair Value Measurements (“ASC 820”) states that fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. The three-tiered fair value hierarchy, which prioritizes which inputs should be used in measuring fair value, is comprised of: (Level I) observable inputs such as quoted prices in active markets; (Level II) inputs other than quoted prices in active markets that are observable either directly or indirectly and (Level III) unobservable inputs for which there is little or no market data. The fair value hierarchy requires the use of observable market data when available in determining fair value. CPS’ marketable securities consist solely of US Government bonds and treasury bills with a maturity of 12 months or less and which fall under Level II of the fair value hierarchy. The value of these securities as of March 28, 2026 was $6,797,952 and, as of December 27, 2025, was $8,769,363.

March 28, 2026December 27, 2025
Cost basis$6,802,5708,769,502
Unrealized gain (loss)$(4,618)139
Total fair value$6,797,9528,769,363

(7) Net Income (Loss) Per Common and Common Equivalent Share

Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted net income (loss) per common share is calculated by dividing net income (loss) by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights. Had there been a profit inQ1 2026, the dilutive effect would have been 364,994 shares. Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive.

The following table presents the calculation of both basic and diluted EPS:

Three Months Ended
March 28, 2026March 29, 2025
Basic EPS Computation:
Numerator:
Net income (loss)$(294,179)$95,962
Denominator:
Weighted average common shares outstanding17,997,08814,525,960
Basic EPS$(0.02)$0.01
Diluted EPS Computation:
Numerator:
Net income (loss)$(294,179)$95,962
Denominator:
Weighted average common shares outstanding17,997,08814,525,960
Dilutive effect of stock options-17,951
Total Shares17,997,08814,543,911
Diluted EPS$(0.02)$0.01

(8) Commitments & Contingencies

Commitments

Operating Leases

The Company hasone real estate lease expiring inFebruary 2028.CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration.None of these equipment leases have been capitalized as the Company elected an accounting policy for short-term leases, which allows lessees to avoid recognizing right-of-use assets and liabilities for leases with terms of12 months or fewer.

The real estate lease expiring in2028 (the “Norton facility lease”) is included as a right-of-use lease asset and corresponding lease liability (current and noncurrent portions) on the balance sheet. This asset and liability was recognized based on the present value of lease payments over the lease term using the Company’s incremental borrowing rate at commencement date. The Company’s lease agreements donot contain any material residual value guarantees or material restrictive covenants.

The Norton facility lease comprises approximately 38 thousand square feet. The lease is triple net lease wherein the Company is responsible for payment of all real estate taxes, operating costs and utilities. The Company also has an option to renew the lease starting inMarch 2028throughFebruary 2032.The Company isnot reasonably certain these extensions will be exercised at this time, and therefore arenot included in the lease asset or liability. Annual rental payments range from $152 thousand to $165 thousand through maturity.

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating leases as ofMarch 28, 2026

(Dollars in Thousands)
Maturity of capitalized lease liabilitiesLease payments
Remaining 2026126
2027169
202828
Total undiscounted operating lease payments$323
Less: Imputed interest(23)
Present value of operating lease liability$300
Balance Sheet Classification
Current lease liability$163
Long-term lease liability137
Total operating lease liability$300
Other Information
Weighted-average remaining lease term for capitalized operating leases (in months)23
Weighted-average discount rate for capitalized operating leases7.3%

Operating Lease Costs and Cash Flows

Operating lease cost and cash paid was $42 thousand during thefirst quarter of2026. This cost is related to its long-term operating lease. All other short-term leases were immaterial.

Finance Leases

The Company doesnot have any finance leases.

(9) Share-Based Payments

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The Company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

During the quarters endedMarch 28, 2026andMarch 29, 2025,a total of 0 and 115,000 stock options, respectively, were granted to employees under the Company’s2020 Equity Incentive Plan (the “Plan”) and a total of 0 and 75,000 stock options, respectively, were granted to outside directors during the quarters endedMarch 28, 2026andMarch 29, 2025.

During the quarters endedMarch 28, 2026and*March 29, 2025,*there were 19,000 and 0 options exercised, respectively.

During the quarters endedMarch 28, 2026and*March 29, 2025,*there were 0 and 45,000 options expired and 2,750 and 0 options forfeited, respectively.

During the quarters endedMarch 28, 2026and*March 29, 2025,*the Company repurchased 671 and 0 shares, respectively for employees to facilitate their exercise of stock options.

There were also 1,046,050 options outstanding at a weighted average price of $2.49 with a weighted average remaining contractual term of 6.8 years as ofMarch 28, 2026and there were 680,475 shares exercisable at a weighted average price of $2.47 with a weighted average remaining term of 6.3 years. There were 1,083,300 options outstanding at a weighted average price of $2.45 with a weighted average remaining contractual term of 7.6 years as ofMarch 29, 2025and there were 581,900 shares exercisable at a weighted average price of $2.37 with a weighted average remaining term of 6.7 years.* The Plan, as amended, is authorized to issue 1,500,000 shares of common stock. As ofMarch 28, 2026,*there were 418,370 shares available for future grants.

As of*March 28, 2026,*there was $418 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 1.81 years.

During the quarters endedMarch 28, 2026and*March 29, 2025,*the Company recognized approximately $48 thousand and $122 thousand, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

(10) Inventories

Inventories consist of the following:

March 28, 2026December 27, 2025
Raw materials$2,984,878$2,559,787
Work in process4,571,3353,449,211
Finished goods310,920278,770
Gross inventory7,867,1336,287,768
Reserve for obsolescence(723,406)(689,361)
Inventories, net$7,143,727$5,598,407

(11) Accrued Expenses

Accrued expenses consist of the following:

March 28, 2026December 27, 2025
Accrued legal and accounting$68,145$101,605
Accrued payroll and related expenses408,373683,631
Accrued other100,701122,674
Total Accrued Expenses$577,219$907,910

(12) Revolving Line of Credit

InMay 2023,the Company entered into a line of credit (LOC) in the amount of $3.0 million with Rockland Trust Company. The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of the National Prime Rate as published by the Wall Street Journal (6.75% atMarch 28, 2026).OnMarch 28, 2026 and March 29, 2025,the Company had $0 of borrowings under this LOC and its borrowing base at the time would have permitted an additional $2.7 million and $3.0 million, respectively, to have been borrowed. The LOC remains in effect until terminated per mutual agreement by both parties. Total interest expense forQ1 2026 was $0 and was $0 forQ1 2025.

(13) Income Taxes

A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely thannot" that all or a portion of deferred tax assets willnot be realized.

The Company believes that it is “more likely thannot” that the Company will be able to fully utilize the deferred tax asset. For thefirst quarter of2026 the deferred tax asset was increased $84 for the estimated tax benefit onQ1 net operating loss.

(14) Enactment of the One Big Beautiful Bill Act

On July 4, 2025, the President signed into law the One Big Beautiful Bill Act (Public Law 119-21), which includes significant modifications to the Internal Revenue Code. The legislation permanently extends and modifies key provisions of the Tax Cuts and Jobs Act of 2017 and introduces new deductions and credits applicable to both individuals and businesses.

Key provisions relevant to the Company include:

Restoration of Immediate Expensing for Domestic Research and Experimental (“R&E”***) Expenditures:***Effective for tax years beginning after December 31, 2024, domestic R&E expenditures may be immediately expensed under new Section 174A, reversing the prior capitalization and amortization requirement. This change may materially impact the Company’s deferred tax assets and current tax expense depending on the volume of qualifying expenditures.

In Q1 2026 the Company expensed $216,914 and in 2025, the Company expensed $867,657 of unamortized Section 174 R&E expenditures

It is anticipated that the unamortized Section 174 R&E expenditures at Q1 2026 will be expensed as follows (subject to further analyses and discussions):

Q2 2026216,914Expense 12.5% of 2022-2024
Q3 2026216,914Expense 12.5% of 2022-2024
Q4 2026216,914Expense 12.5% of 2022-2024
Totals650,742

***Enhancement of Section 179 Expensing:***The maximum Section 179 deduction is increased to $2.5 million, with a phase-out threshold beginning at $4 million. This expansion is expected to accelerate tax deductions for qualifying property and benefit capital investment strategies.

***Permanent Reinstatement of 100% Bonus Depreciation:***For qualified property acquired and placed in service after January 19, 2025, the Company may elect full expensing under Section 168(k), which is expected to accelerate tax deductions and reduce taxable income in applicable periods.

***Modifications to FDII (now FDDEI):***The deduction under Section 250 for foreign-derived intangible income is reduced to 33.34%, and eligibility criteria are narrowed. These changes may impact export-related tax incentives and deferred tax projections tied to U.S.-held IP.

The Company is currently evaluating the impact of these provisions on its financial statements and tax positions. While the changes are not expected to materially affect prior period results, they may influence future effective tax rates, deferred tax balances, and cash tax obligations. The Company incorporated these changes into its tax planning and provision calculations for fiscal year 2025 and beyond. However, the full effect of these provisions will depend on the Company's future capital expenditures, R&E activities, financing arrangements, and international operations.

(15)Segment Reporting

The Company views its operations and manages its business asone segment. The Company produces and sells advanced material solutions, primarily metal matrix composites, to assemblers of high density electronics and other specialty components and subassemblies. The Company also assembles housings and packages for hybrid circuits, selling to the same customers mentioned above. These customers represent a single market or segment with similar stringent and well-defined requirements. The Company’s customers, in turn, sell the components and subassemblies which incorporate the products into many different end markets, however, these end markets aretwo tothree levels removed from the Company. The Company also sells armor strike faces to armor manufacturers, using the same manufacturing process used in its other product solutions. The Company makes operating decisions and assesses financial performance only for the Company as a whole and doesnot make operating decisions or assess financial performance by the end markets which ultimately use the products. Our chief operating decision maker (CODM) is Brian Mackey, our President and CEO. The Company's CODM regularly reviews financial information presented and does not evaluate the Company's operating segment using asset or liability information. Instead, the CODM uses revenue, gross margin, and net income or loss to allocate operating and capital resources and assess performance by comparing actual results to historical results and previously forecasted financial information.

The following table presents segment information for the Company's single reporting segment:

March 28, 2026March 29, 2025
Product sales$7,028,748$7,505,921
Cost of product sales6,421,8706,274,920
Gross profit606,8781,231,001
Selling, general, and administrative expenses1,129,5121,101,350
Income (loss) from operations(522,634)129,651
Other income, net146,20550,476
Income (loss) before income tax(376,429)180,127
Income tax provision (benefit)(82,250)84,165
Net income (loss)$(294,179)$95,962
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.